BENEVICH ERIC
SEC insider (Form 3/4/5 filer). CIK 0001643653. Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX) and 1 other issuer. 30 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in SAN DIEGO, CA.
Companies BENEVICH ERIC has filed insider reports for
- NEUROCRINE BIOSCIENCES INC (NBIX): Officer, Chief Commercial Officer
- aTYR PHARMA INC (ATYR): Director
BENEVICH ERIC
CIK: 0001643653
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect3.4K shares at avg. $156.22$529K - Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirect6.3K shares- - Sep 9, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect3.2K shares at avg. $43.24$138K - Sep 9, 2026NBIX
NEUROCRINE BIOSCIENCES INC
SaleDirect2.2K shares at avg. $154.61$333K - May 11, 2026ATYR
aTYR PHARMA INC
AwardDirectStock Option (right to buy)
50K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect2K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect9K shares at avg. $124.12$1.1M - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect2.1K shares- - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect1.1K shares at avg. $124.12$140K - Feb 13, 2026NBIX
NEUROCRINE BIOSCIENCES INC
Tax PaymentDirect1.1K shares at avg. $124.12$131K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 3,386 | $156.22 | $528,961 | Direct |
| Sep 11, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award | 6,275 | - | $0 | Direct |
| Sep 9, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 3,194 | $43.24 | $138,109 | Direct |
| Sep 9, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Sale | 2,154 | $154.61 | $333,030 | Direct |
| May 11, 2026 |  ATYR aTYR PHARMA INC | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,961 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 8,963 | $124.12 | $1,112,488 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 2,083 | - | $0 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 1,124 | $124.12 | $139,511 | Direct |
| Feb 13, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Tax Payment | 1,058 | $124.12 | $131,319 | Direct |
1-10 of 30 transactions